Nasim Massah

Nasim Massah currently serves as an NGS Scientist in Translational Pathology within Translational Sciences Management at Pfizer since July 2024. Prior to this role, Nasim held various positions at Adaptive Biotechnologies Corp. from January 2017 to March 2024, including Manager of Molecular Research and Senior Research Scientist. Nasim's career began at the Canadian Pharmacogenomics Network for Drug Safety at BC Children's Hospital Research Institute, working as a Research Scientist from September 2011 to December 2016. Additional experience includes multiple roles at The University of British Columbia, where Nasim contributed as a Research Scientist and Research Assistant between 2006 and 2011. Educationally, Nasim completed a Master of Science (MSc) in Population Genetics at The University of British Columbia from 2006 to 2009.